ClinicalTrials.gg
Not yet recruitingNCT07458412DRA-SCUpdated Mar 9, 2026

Impact of Diastasis Recti Abdominis on Spinal Curvature in Postpartum Women

An observational study in Diastasis Recti Abdominis, Lumbar Lordosis and Thoracic Kyphosis, sponsored by Cairo University. Not yet recruiting. Open to female participants aged 21 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-03-09.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
110
Ages
21 Years to 35 Years
Sex
Female
01

Study summary

This study investigates the relationship between diastasis recti abdominis and spinal curvature in postpartum women using non-invasive assessment methods.

Read the detailed description

Postpartum musculoskeletal changes are common and may significantly affect spinal alignment and overall physical function. Diastasis recti abdominis (DRA), a separation of the abdominal muscles after pregnancy, is frequently reported among postpartum women and may contribute to alterations in trunk stability and posture. Despite its high prevalence, the potential association between DRA and spinal curvature has not been sufficiently clarified. Understanding this relationship is important, as changes in spinal alignment-such as increased lumbar lordosis or thoracic kyphosis-may influence pain, functional ability, and long-term musculoskeletal health. Therefore, further investigation is needed to better define the connection between DRA and spinal curvature in order to support early assessment and improve postpartum rehabilitation strategies.

02

Conditions studied

  • Diastasis Recti Abdominis
  • Lumbar Lordosis
  • Thoracic Kyphosis

Browse trials for

03

In context

Lordosis

30 studies on the registry are indexed under Lordosis; 5 are open to participants now.

This study's planned enrollment of 110 is above the median of 59 across 14 observational studies indexed under Lordosis.

Browse Lordosis studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 35 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

The study population will include postpartum women who meet the eligibility criteria. Participants will be divided into two groups based on the presence or absence of diastasis recti abdominis and will undergo non-invasive assessment of spinal curvature for comparative analysis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age range: 21 to 35 years
  • between 18 and 29.9 kg/m².
  • Normal vaginal delivery or cesarean section.
  • Postpartum period between 6 weeks and 6 months
  • Participants with or without diastasis recti abdominis (DRA) as determined by ultrasound.

Exclusion criteria

Exclusion Criteria:

    • History of spinal deformities (e.g., scoliosis, kyphosis, spondylolisthesis).

      • Any neuromuscular or neurological disorders.
      • Previous abdominal or spinal surgery.
      • Multiple pregnancies.
      • Participants currently undergoing physical therapy treatment for spinal or abdominal conditions.
      • Inability to comply with instructions or complete the assessment protocol
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
110 participants (estimated)
Patient registry
No

Groups and cohorts

  • Women with Diastasis Recti

    Postpartum women diagnosed with diastasis recti abdominis. Participants will undergo non-invasive assessment of spinal curvature for comparison purposes. No intervention will be administered.

  • Women without Diastasis Recti

    Postpartum women without diastasis recti abdominis. Participants will undergo non-invasive assessment of spinal curvature for comparison purposes. No intervention will be administered.

06

What researchers measure

Primary outcomes

  1. Lumbar Lordosis Angle

    Lumbar lordosis angle measured in degrees in postpartum women with and without diastasis recti abdominis using a non-invasive assessment method.

    Time frame: At baseline (single assessment).

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07458412
Lead sponsor
Cairo University
Responsible party
Mawada Mohamed Ali Altemamy (Principal Investigator, Cairo University) — Principal investigator
First posted
Mar 9, 2026
Start date
Mar 2, 2026 (estimated)
Primary completion
Apr 20, 2026 (estimated)
Completion
Apr 27, 2026 (estimated)
Last update
Mar 9, 2026

Study contacts

Mawada Mohamed, Master
Contact
mawadamohamed45@gmail.com
+01027877397

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion